Oct 11, 2017 ... Williams v. Bayer Healthcare Pharmaceuticals, Inc. et al (1:17-cv-07816), New York Southern District Court, Filed: 10/11/2017 - PacerMonitor ...
6 days ago ... Other case filed on October 13, 2017 in the New York Southern District Court.
Mar 30, 2017 ... District of Mississippi: Northern District of Alabama. BRIDGES, ET AL. v. BAYER HEALTHCARE PHARMACEUTICALS, INC., ET AL.,. C.A. No.
Dec 17, 2014 ... Case opinion for US 8th Circuit TOWNSEND v. Bayer HealthCare Pharmaceuticals Inc., Defendant–Appellant.. Read the Court's full decision ...
Attorneys for Defendants Bayer HealthCare Pharmaceuticals Inc. and. Janssen ... NastLaw LLC Mark A. Hoffman, Esquire. 1 101 Market Street, ... Ann Espersen and Charles Espersen V. Janssen Pharmaceuticals, Inc., et al., Jan. 2016, No.
Results: Safety analyses included 825 OCR- vs 826 IFNβ-1a‒treated patients ... Almiral, Bayer, Biogen, Chugai, CSL Behring, F. Hoffmann-La Roche Ltd., Genzyme, ... Gavin Giovannoni has received honoraria from AbbVie, Bayer HealthCare, ... Almirall, Bayer Health Care Pharmaceuticals, CLC Behring, Genentech, Inc., ...
Nov 16, 2011 ... This remains a major challenge (Gonzalez-Angulo et al., 2007) and it is ... its specific and superior tubulin targeting activity (Hoffmann et al., ..... synthesized at Bayer Healthcare Pharmaceuticals (Berlin, Germany) through total syntheses. .... h with 0.076 μL DharmaFECT® 2 (Dharmacon, Inc., Lafayette, CO, ...
The 1996 vs 2013 multiple sclerosis phenotype descriptions for relapsing disease ..... boards/DSMB: Bayer HealthCare Pharmaceuticals, Biogen Idec, EMD Serono, Inc., Novartis, ... Genentech, F. Hoffmann-LaRoche, Ironwood Pharmaceuticals Inc., ISIS Pharmaceuticals Inc., .... Kappos L, Polman CH, Freedman MS, et al.
12255-NMG. ▫ Bayer Pharma AG, Bayer Intellectual Property GMBH and Bayer Healthcare Pharmaceuticals, INC. v. ... Teva Pharmaceuticals USA, Inc., et al. and Sun Pharmaceuticals ... Apotex Inc. and Apotex Corp.; Hoffmann-LaRoche Inc. v.